CSI Market
Sign In | Register

Acumen Pharmaceuticals Inc (ABOS) Annual Balance Sheets

Annual · GAAP · USD millions
Access ABOS quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Acumen Pharmaceuticals Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ABOS/balance-sheets
https://api.csimarket.com/api/v1/companies/ABOS/fundamentals
https://api.csimarket.com/api/v1/companies/ABOS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent53.99
Marketable Securities, Current SH62.88
Cash & Short-term Investments115.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.39
Total Current Assets122.25
Equipment/Property/Plant Net0.00
Long-term investments0.00
Other Assets, Noncurrent0.58
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Operating Lease Right Of Use Asset-
Total Assets122.83
Liabilities
Accounts Payable, Current AC0.55
Accrued Liabilities, Current AC10.07
Short-term Debt DE18.77
Other Liabilities, Current0.00
Total Current Liabilities30.01
Long-term debt22.40
Total Long-term Debt22.40
Combined Long+Short Total Debt (filer-reported)31.16
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Accrued Clinical Trial Expenses Current10.62
Total Liabilities52.40
Stockholders' Equity
Aoci Before Tax Attributable To Parent-
Common Stock Value0.01
Additional Paid In Capital Common Stock516.80
Retained Earnings / Accumulated Deficit-446.46
Other Equity0.08
Common Stockholder's Equity70.43
Total Stockholder's Equity70.43
Liabilities & Stockholder's Equity122.83
4 historic quarters locked

Sign in to unlock the full Acumen Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Acumen Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-021413

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI